How biotechs can rethink their strategies after the market downturn
https://www.mckinsey.com/industries/life-sciences/our-insights/how-biotechs-can-rethink-their-strategies-after-the-market-downturn
Biotech stocks have taken a hit, but the sector will probably rebound. Companies can navigate the downturn by scrutinizing cash management and financing and rethinking paths to long-term value creation.
https://www.mckinsey.com/industries/life-sciences/our-insights/how-biotechs-can-rethink-their-strategies-after-the-market-downturn
Biotech stocks have taken a hit, but the sector will probably rebound. Companies can navigate the downturn by scrutinizing cash management and financing and rethinking paths to long-term value creation.